Although the risk for EALwas not related to XRCC6 rs5751129 or XRCC4rs6869366 variants, the 30-bp deletion within the third intron ofXRCC4 influenced the risk of ALL with KMT2A-rcases. This evidence concerns the gene XRCC6 and acute lymphoblastic leukemia.